DSP and idiopathic pulmonary fibrosis: In an IPF patient cohort from the Czech group of the EMPIRE registry, IPF patients carrying the DSP rs2076295 G allele were found to have better clinical responses to nintedanib, with longer overall survival and a slower rate of lung function decline compared with TT genotype carriers, while TT homozygotes benefited most from pirfenidone [23].